Renovaro Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.797
+0.082 (11.47%)
At close: Jan 22, 2025, 4:00 PM
0.792
-0.005 (-0.58%)
After-hours: Jan 22, 2025, 4:06 PM EST
Renovaro Market Cap
Renovaro has a market cap or net worth of $126.48 million as of January 22, 2025. Its market cap has decreased by -47.03% in one year.
Market Cap
126.48M
Enterprise Value
132.85M
1-Year Change
-47.03%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since December 11, 2018, Renovaro's market cap has decreased from $252.00M to $126.48M, a decrease of -49.81%. That is a compound annual growth rate of -10.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 113.50M | -14.47% |
| Dec 31, 2024 | 132.70M | -37.23% |
| Dec 29, 2023 | 211.40M | 287.89% |
| Dec 30, 2022 | 54.50M | -85.68% |
| Dec 31, 2021 | 380.70M | 176.67% |
| Dec 31, 2020 | 137.60M | -40.77% |
| Dec 31, 2019 | 232.30M | -8.25% |
| Dec 31, 2018 | 253.20M | 0.48% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |